Ensuring Recruitment And Compliance Success Of An Evolving Rare Neuromuscular Disease Study
Source: Advarra

A biotech company planned a global Phase 3 study and expansion of a rare neuromuscular disease over three years. Given the disease's rapid progression and impact on patients' motor and cognitive functions, efficient trial operations and participant support were crucial. To achieve success, the study team chose the Longboat Platform to train all site staff, offer recruitment and engagement resources, and ensure participants and caregivers received necessary support throughout the trial.
Uncover the details of what happened next by downloading the case study below.
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
Advarra
This website uses cookies to ensure you get the best experience on our website. Learn more